Clinical Trial Update: A Study of LY3303560 in Participants With Early Symptomatic Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LY3303560 in early symptomatic Alzheimer's disease; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LY3303560

Snippet

Sponsor: Eli Lilly and Company | Conditions: Alzheimer Disease (AD) | Phase 2 | Status: COMPLETED | Results posted: 2022-08-30